INDOCO REMEDIES : USFDA INSPECTION | 7 OBSERVATIONS
• USFDA inspected the company’s Plant II (Sterile), Goa from Aug 27–Sep 4, 2026.
• Inspection concluded with 7 observations in Form 483.
• Company is addressing the observations and will submit a response to USFDA within the stipulated timeline.
3
1
1September 7, 2026 1.7K